MX2009005507A - Derivados de espiro-piperidina. - Google Patents

Derivados de espiro-piperidina.

Info

Publication number
MX2009005507A
MX2009005507A MX2009005507A MX2009005507A MX2009005507A MX 2009005507 A MX2009005507 A MX 2009005507A MX 2009005507 A MX2009005507 A MX 2009005507A MX 2009005507 A MX2009005507 A MX 2009005507A MX 2009005507 A MX2009005507 A MX 2009005507A
Authority
MX
Mexico
Prior art keywords
sup
spiro
present
piperidine derivatives
compounds
Prior art date
Application number
MX2009005507A
Other languages
English (en)
Inventor
Mark Rogers-Evans
Raffaello Masciadri
Patrick Schnider
Hasane Ratni
Caterina Bissantz
Christophe Grundschober
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2009005507A publication Critical patent/MX2009005507A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se relaciona con nuevos derivados de indol-2-il-carbonil-espiro-piperidina que actúan como antagonistas del receptor de V1a, con su manufactura, con composiciones farmacéuticas que los contienen y con su uso como medicamentos. Los compuestos activos de la presente invención son útiles para la prevención y/o tratamiento de la ansiedad, trastornos depresivos y otras enfermedades. Los compuestos de la presente invención tienen la fórmula general (I), en donde R1 a R11 y X tienen los significados definidos en la descripción.
MX2009005507A 2006-12-07 2007-11-27 Derivados de espiro-piperidina. MX2009005507A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125645 2006-12-07
PCT/EP2007/062857 WO2008068159A1 (en) 2006-12-07 2007-11-27 Spiro-piperidine derivatives

Publications (1)

Publication Number Publication Date
MX2009005507A true MX2009005507A (es) 2009-06-03

Family

ID=39201604

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005507A MX2009005507A (es) 2006-12-07 2007-11-27 Derivados de espiro-piperidina.

Country Status (21)

Country Link
US (2) US7432259B2 (es)
EP (1) EP2099799B1 (es)
JP (1) JP2010511654A (es)
KR (1) KR101111022B1 (es)
CN (1) CN101541797A (es)
AR (1) AR064136A1 (es)
AT (1) ATE469899T1 (es)
AU (1) AU2007329066B2 (es)
BR (1) BRPI0720246A2 (es)
CA (1) CA2670671A1 (es)
CL (1) CL2007003483A1 (es)
DE (1) DE602007006989D1 (es)
ES (1) ES2343286T3 (es)
IL (1) IL198549A0 (es)
MX (1) MX2009005507A (es)
NO (1) NO20091766L (es)
PE (1) PE20081489A1 (es)
RU (1) RU2009119393A (es)
TW (1) TW200843758A (es)
WO (1) WO2008068159A1 (es)
ZA (1) ZA200903175B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2418801C2 (ru) * 2005-09-28 2011-05-20 Ф. Хоффманн-Ля Рош Аг Индол-3-ил-карбонил-азаспиропроизводные в качестве антагонистов рецептора вазопрессина
ES2402000T3 (es) * 2009-01-30 2013-04-26 F. Hoffmann-La Roche Ag Derivados piperidina como antagonistas del receptor NK3
US8324250B2 (en) * 2009-03-19 2012-12-04 Hoffmann-La Roche Inc. Piperidine derivatives as NK3 receptor antagonists
EA029167B1 (ru) * 2013-12-19 2018-02-28 Ф. Хоффманн-Ля Рош Аг Спиро-оксазолоны
CA3072766A1 (en) * 2017-09-05 2019-03-14 Blackthorn Therapeutics, Inc. 2,6-diazaspiro[3.3]hepatan-2-yl derivatives and pharmaceutical compostions thereof useful as vasopressin receptor antagonists
WO2020048826A1 (en) 2018-09-03 2020-03-12 Bayer Aktiengesellschaft 5-substituted 1-oxa-3,9-diazaspiro[5.5]undecan-2-one compounds
WO2020048828A1 (en) 2018-09-03 2020-03-12 Bayer Pharma Aktiengesellschaft 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds
WO2020048830A1 (en) 2018-09-03 2020-03-12 Bayer Aktiengesellschaft 5-aryl-3,9-diazaspiro[5.5]undecan-2-one compounds
WO2020048829A1 (en) 2018-09-03 2020-03-12 Bayer Aktiengesellschaft 3,9-diazaspiro[5.5]undecane compounds
WO2020048831A1 (en) 2018-09-03 2020-03-12 Bayer Aktiengesellschaft 5-aryl-3,9-diazaspiro[5.5]undecan-2-one compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5150201A1 (es) 1998-09-07 2002-04-29 Hoffmann La Roche Derivados de piperidina
DK1283838T3 (da) 2000-05-12 2004-03-22 Solvay Pharm Bv Piperazin- og piperidinforbindelser
CA2501539A1 (en) 2002-10-17 2004-04-29 Amgen Inc. Benzimidazole derivatives and their use as vanilloid receptor ligands
OA13347A (en) * 2003-12-22 2007-04-13 Pfizer Triazole derivatives as vasopressin antagonists.
US7351706B2 (en) 2006-01-05 2008-04-01 Hoffmann-La Roche Inc. Indol-3-yl-carbonyl-spiro-piperidine derivatives

Also Published As

Publication number Publication date
DE602007006989D1 (en) 2010-07-15
WO2008068159A1 (en) 2008-06-12
AR064136A1 (es) 2009-03-18
RU2009119393A (ru) 2011-01-20
KR20090080112A (ko) 2009-07-23
ATE469899T1 (de) 2010-06-15
CA2670671A1 (en) 2008-06-12
CN101541797A (zh) 2009-09-23
IL198549A0 (en) 2010-02-17
CL2007003483A1 (es) 2008-07-04
ES2343286T3 (es) 2010-07-27
ZA200903175B (en) 2010-03-31
NO20091766L (no) 2009-07-06
AU2007329066B2 (en) 2012-04-12
PE20081489A1 (es) 2008-10-30
EP2099799A1 (en) 2009-09-16
US8022213B2 (en) 2011-09-20
AU2007329066A1 (en) 2008-06-12
TW200843758A (en) 2008-11-16
JP2010511654A (ja) 2010-04-15
US7432259B2 (en) 2008-10-07
US20080161299A1 (en) 2008-07-03
BRPI0720246A2 (pt) 2013-12-31
KR101111022B1 (ko) 2012-03-14
EP2099799B1 (en) 2010-06-02
US20080161298A1 (en) 2008-07-03

Similar Documents

Publication Publication Date Title
WO2008080844A9 (en) Azaspiro derivatives
MX2009005507A (es) Derivados de espiro-piperidina.
MX2009007411A (es) Derivados de espiropiperidina-glicinamida.
NO20074592L (no) Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister
MX2009006540A (es) Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides.
HK1098460A1 (en) Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders
MY147588A (en) (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
MX2010004026A (es) Piperidino-dihidrotienopirimidinas sustituidas.
MX2010005861A (es) Agonistas novedosos de los receptores de glucocorticoides.
IL176546A0 (en) Imidazoline derivatives having cb1-antagonistic activity
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
GEP20135744B (en) Quinuclidine carbonate derivatives and medicinal compositions containing the same
MX2009006454A (es) Derivados de espiro-piperidina.
ES2193875A1 (es) Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
MX2009005544A (es) Indoles.
MY183111A (en) 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
MX2009006010A (es) Derivados de amina y su uso en enfermedades mediadas por el adrenoreceptor beta 2.
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
MX2009005541A (es) Indoles que actuan como antagonistas del receptor v1a.
MX2009005504A (es) Derivados de espiro piperidina como antagonistas del receptor via.
MX2009006446A (es) Derivados de espiro-piperidina.
MX2009006920A (es) Indoles.
UA93878C2 (ru) Производная бензилпиперазина, ee применение при лечении разных расстройств и фармацевтическая композиция, которая ee содержит
UA98126C2 (ru) Производные индазолильного эстера и амида для лечения расстройств, опосредованных глюкокортикоидным рецептором

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration